Mind Over Matter: Decoding China’s BCI Push

A Chinese man who lost all four limbs in a high-voltage electrical accident 13 years ago can now play chess and racing g...

November 1, 2025 | Saturday | Analysis
Private Market Vaccines Drive Growth and Strategy Shifts Across China

HPV and PCV are the leading vaccines in the self-paid market in China. According to the WHO vaccine market report 2024, ...

November 1, 2025 | Saturday | Opinion
Everest Medicines inks $89 M deal with NovaBridge for treating eye disorders in Asia

Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commer...

October 31, 2025 | Friday | News
KLN Medical to distribute Siemens Healthineers' point-of-care testing products in Hong Kong

KLN Logistics has announced a strategic partnership between its healthcare subsidiary, KLN Medical and global medic...

October 28, 2025 | Tuesday | News
Hong Kong introduces most extensive data platform for advancing cancer immunotherapy research

A clinical oncology research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration...

October 27, 2025 | Monday | News
HUKST designs SmartPath AI system to streamline cancer pathology workflow

The Hong Kong University of Science and Technology (HKUST) has launched SmartPath, a comprehensive artificial intel...

October 23, 2025 | Thursday | News
API China returns with 93rd edition to strengthen its role as Asia’s pharma powerhouse

API China, Asia’s authoritative exhibition for pharmaceutical ingredients and manufacturing, will convene its 93rd...

October 22, 2025 | Wednesday | News
Vision Science and Technology invests HK$5 M for myopia and presbyopia management

The Hong Kong Polytechnic University (PolyU) has received funding support of HK$5 million from Vision Science and Techno...

October 21, 2025 | Tuesday | News
Oceanpine Capital acquires 80% equity interest in Beijing Jacoray Pharma for RMB 200 M

Jacobio Pharma has announced that its subsidiary Beijing Jacobio Pharmaceuticals Co. has entered into a Capital Increase...

October 16, 2025 | Thursday | News
NUS Medicine and Tsinghua University researchers develop next-gen mRNA vaccine platform

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and China's ...

October 15, 2025 | Wednesday | News
Roche collaborates with OASES to strengthen Hong Kong's position as global healthcare hub

Roche has announced its strategic collaboration with the Office for Attracting Strategic Enterprises (OASES) to accelera...

October 13, 2025 | Monday | News
Mirxes' non-invasive microRNA blood test secures approval in China for gastric cancer screening

Mirxes, a leading and only publicly-listed molecular cancer  early detection company in Asia Pacific,  has bee...

October 9, 2025 | Thursday | News
IHH Healthcare Launches a Global Incubator Programme to Drive Next-Generation Healthcare Innovations

Image Caption: (From left) :: Ashok Pandit, Group Chief Corporate Officer, IHH Healthcare | Dr Prem Kumar Nair...

October 8, 2025 | Wednesday | News
China approves first and only Remote Electrical Neuromodulation based migraine treatment

Pier 88 Health, a digital health company dedicated to reshaping chronic pain management and bringing breakthrough global...

October 3, 2025 | Friday | News
Hong Kong's Health Hope Pharma enters into virology deal with Gilead Sciences

Health Hope Pharma (HHP), a clinical-stage oncology biopharma company headquartered in Hong Kong, has entered into ...

September 30, 2025 | Tuesday | News
WuXi Biologics launches targeted integration cell line platform to accelerate biologics development

China's WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has ann...

September 26, 2025 | Friday | News
Global expansion of Idorsia’s QUVIVIQ continues as Simcere launches in China

Simcere Pharmaceuticals Group has launched QUVIVIQ® (daridorexant) in China. In 2022, Idorsia an...

September 23, 2025 | Tuesday | News
China approves world's first dual GCG/GLP-1 receptor for glycemic control in type 2 diabetes

Innovent Biologics, Inc. has announced that China's National Medical Products Administration (NMPA) has approved mazduti...

September 22, 2025 | Monday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls